Nucleophosmin 1 (NPM1) is one of the most common gene mutations in AML, found in one-third of newly diagnosed AMLs occurring in 25–30% of adult AML patients and in 10% of pediatric AML patients. Here, NPM1 is linked to acute myeloid leukemia.